Transcriptional profiling reveals complex regulation of the monocyte IL-1β system by IL-13

被引:104
作者
Scotton, CJ
Martinez, FO
Smelt, MJ
Sironi, M
Locati, M
Mantovani, A
Sozzani, S
机构
[1] Univ Brescia, Sect Gen Pathol & Immunol, I-25123 Brescia, Italy
[2] Univ Milan, Ist Ric Farmacol Mario Negri, Milan, Italy
[3] Univ Milan, Sect Gen Pathol, Milan, Italy
关键词
D O I
10.4049/jimmunol.174.2.834
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-4 and IL-13 are prototypic Th2 cytokines that generate an "alternatively activated" phenotype in macrophages. We used high-density oligonucleotide microarrays to investigate the transcriptional profile induced in human monocytes by IL-13. After 8-h stimulation with IL-13, 142 genes were regulated (85 increased and 57 decreased). The majority of these genes were related to the inflammatory response and innate immunity; a group of genes related to lipid metabolism was also identified, with clear implications for atherosclerosis. In addition to characteristic markers of alternatively activated macrophages, a number of novel IL-13-regulated genes were seen. These included various pattern recognition receptors, such as CD1/b/c/e, TLR1, and C-type lectin superfamily member 6. Several components of the IL-1 system were regulated. IL-1RI, IL-1RII, and IL-1Ra were all up-regulated, whereas the IL-1beta-converting enzyme, caspase 1, and IRAK-M were down-regulated. LPS-inducible caspase 1 enzyme activity was also reduced in IL-13-stimulated monocytes, with a consequent decrease in pro-IL-1beta processing. These data reveal that IL-13 has a potent effect on the transcriptional profile in monocytes. The IL-13-induced modulation of genes related to IL-1 clearly highlights the tightly controlled and complex levels of regulation of the production and response to this potent proinflammatory cytokine.
引用
收藏
页码:834 / 845
页数:12
相关论文
共 76 条
[31]   NF-Y HAS A NOVEL ROLE IN STEROL-DEPENDENT TRANSCRIPTION OF 2 CHOLESTEROGENIC GENES [J].
JACKSON, SM ;
ERICSSON, J ;
OSBORNE, TF ;
EDWARDS, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21445-21448
[32]   PPAR-γ agonists inhibit production of monocyte inflammatory cytokines [J].
Jiang, CY ;
Ting, AT ;
Seed, B .
NATURE, 1998, 391 (6662) :82-86
[33]   IL-4/IL-13 signaling beyond JAK/STAT [J].
Jiang, H ;
Harris, MB ;
Rothman, P .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (06) :1063-1070
[34]   Interleukin-13 stimulates the transcription of the human α2(I) collagen gene in human dermal fibroblasts [J].
Jinnin, M ;
Ihn, H ;
Yamane, K ;
Tamaki, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (40) :41783-41791
[35]   Chemokine production by human vascular smooth muscle cells: modulation by IL-13 [J].
Jordan, NJ ;
Watson, ML ;
Williams, RJ ;
Roach, AG ;
Yoshimura, T ;
Westwick, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (04) :749-757
[36]   Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy [J].
Jung, M ;
Sabat, R ;
Krátzschmar, J ;
Seidel, H ;
Wolk, K ;
Schönbein, C ;
Schütt, S ;
Friedrich, M ;
Döcke, WD ;
Asadullah, K ;
Volk, HD ;
Grütz, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2004, 34 (02) :481-493
[37]   Cholesterol biosynthesis from lanosterol - A concerted role for Sp1 and NF-Y-binding sites for sterol-mediated regulation of rat 7-dehydrocholesterol reductase gene expression [J].
Kim, JH ;
Lee, JN ;
Paik, YK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :18153-18160
[38]   Suppressors of cytokine signaling and immunity [J].
Kubo, M ;
Hanada, T ;
Yoshimura, A .
NATURE IMMUNOLOGY, 2003, 4 (12) :1169-1176
[39]   Regulation of interleukin 3 receptor α chain (IL-3Rα) on human monocytes by interleukin (IL)-4, IL-10, IL-13, and transforming growth factor β (TGF-β) [J].
Leveque, C ;
Grafte, S ;
Paysant, J ;
Soutif, A ;
Lenormand, B ;
Vasse, M ;
Soria, C ;
Vannier, JP .
CYTOKINE, 1998, 10 (07) :487-494
[40]   IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype [J].
Loke P. ;
Nair M.G. ;
Parkinson J. ;
Guiliano D. ;
Blaxter M. ;
Allen J.E. .
BMC Immunology, 3 (1)